Canaan Inc. (CAN)
| Market Cap | 448.55M |
| Revenue (ttm) | 220.72M |
| Net Income (ttm) | -366.75M |
| Shares Out | 194.18M |
| EPS (ttm) | -0.31 |
| PE Ratio | n/a |
| Forward PE | 2.15 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 41,864,790 |
| Open | 2.92 |
| Previous Close | 2.81 |
| Day's Range | 2.20 - 2.96 |
| 52-Week Range | 1.13 - 3.98 |
| Beta | 2.98 |
| Analysts | Strong Buy |
| Price Target | 4.25 (+83.98%) |
| Earnings Date | Nov 28, 2023 |
About CAN
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore. [Read more]
Financial Performance
In 2022, Canaan's revenue was 634.94 million, a decrease of -12.19% compared to the previous year's 723.07 million. Earnings were 70.52 million, a decrease of -75.69%.
Financial numbers in CNY Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for CAN stock is "Strong Buy." The 12-month stock price forecast is $4.25, which is an increase of 83.98% from the latest price.
News
Theralase Release's 3Q2023 Interim Financial Statements
TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research a...
Theralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research a...
Canaan Inc. Reports Unaudited Third Quarter 2023 Financial Results
SINGAPORE , Nov. 28, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced its unaudited financial result...
Canaan Inc. to Report Third Quarter 2023 Financial Results on November 28, 2023
SINGAPORE , Nov. 20, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its fi...
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
TORONTO, ON / ACCESSWIRE / November 17, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research a...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ("...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Canaan Inc. - CAN
NEW YORK , Oct. 9, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Canaan Inc. ("Canaan" or the "Company") (NASDAQ: CAN). Such investors are advised to contact Rob...
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ...
CAN EQUITY NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Canaan Inc. Investors to Inquire About Securities Class Action Investigation - CAN
NEW YORK , Sept. 21, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Canaan Inc. (N...
Theralase(R) Grants Stock Options
TORONTO, ON / ACCESSWIRE / September 21, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ...
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 13, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ...
Canaan Inc. Celebrates Its 10th Anniversary at Avalon Bitcoin & Crypto Day
SINGAPORE , Sept. 11, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that the Company will host Av...
Canaan Inc. to Participate in H.C. Wainwright 25th Annual Global Investment Conference on September 12, 2023
SINGAPORE , Sept. 11, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that the Company will partici...
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 8, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. (...
Canaan Inc. Reports Unaudited Second Quarter 2023 Financial Results
- Total Computing Power Sold Achieved 6.1 Million Thash/s, up 45.2% QoQ - - Bitcoin Mining Revenues Reached US$15.9 Million, up 43.3% QoQ - SINGAPORE, Aug. 29, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Canaan Inc. ("C...
Canaan Inc. to Report Second Quarter 2023 Financial Results on August 29, 2023
SINGAPORE , Aug. 23, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its fi...
CAN INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Canaan Inc. Investors to Inquire About Securities Class Action Investigation - CAN
NEW YORK , Aug. 22, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Canaan Inc. (NAS...
TOP RANKED ROSEN LAW FIRM Encourages Canaan Inc. Investors to Inquire About Securities Class Action Investigation – CAN
NEW YORK--(BUSINESS WIRE)---- $CAN #CAN--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Canaan Inc. (NAS...
Canaan Inc. Provides Updates on Its Bitcoin Mining Operations
SINGAPORE , Aug. 18, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company" or "We"), a leading high-performance computing solutions provider, today announced that the challenges se...
Theralase(R) Closes Non-Brokered Private Placement Equity Financing
TORONTO, ON / ACCESSWIRE / June 30, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and de...
Canaan Inc. to Participate in Cantor Technology Conference on June 14-15, 2023
SINGAPORE , June 12, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that Canaan's Group Senior Inv...
Canaan Inc. Reports Unaudited First Quarter 2023 Financial Results
- Total Computing Power Sold Rebounded to 4.2 Million Thash/s, up 126.8% QoQ - SINGAPORE , May 26, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performanc...
Canaan Inc. to Report First Quarter 2023 Financial Results on May 26, 2023
SINGAPORE , May 19, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its fin...